D010180ProceduresE04.210.7526100.99481PancreatectomyFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.6277770.01835176research area of0.758290.073789614subject area for31537303Chivukula SV, Tierney JF, Hertl M, Poirier J, Keutgen XMSurgeryOperative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients? Surgery. 2020 01; 167(1):180-186.Surgery2019-09-16T00:00:002019Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?PathologyRadiation OncologyDanielDezielDaniel Deziel349242Deziel, DanielProfessorPaoloGattusoPaolo Gattuso349288Gattuso, PaoloProfessorSurgeryJonathanMyersJonathan Myers349466Myers, JonathanProfessorEdwardHollingerEdward Hollinger349560Hollinger, EdwardAssistant ProfessorRossAbramsRoss Abrams349600Abrams, RossProfessor6Assistant Professor4Professor32151358Vaghaiwalla T, Keutgen XMSurgical oncology clinics of North AmericaSurgical Management of Pancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am. 2020 Apr; 29(2):243-252.Surg Oncol Clin N Am2020-04-01T00:00:002020Surgical Management of Pancreatic Neuroendocrine Tumors.25456943Cherenfant J, Talamonti MS, Hall CR, Thurow TA, Gage MK, Stocker SJ, Lapin B, Wang E, Silverstein JC, Mangold K, Odeleye M, Kaul KL, Lamzabi I, Gattuso P, Winchester DJ, Marsh RW, Roggin KK, Bentrem DJ, Baker MS, Prinz RASurgeryComparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2014 Dec; 156(6):1504-10; discussion 1510-1.Surgery2014-11-11T00:00:002014Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors.22375521Abrams RAExpert review of gastroenterology & hepatologyRadiotherapy in the adjuvant management of pancreatic adenocarcinoma: is it helpful? Expert Rev Gastroenterol Hepatol. 2012 Apr; 6(2):149-61.Expert Rev Gastroenterol Hepatol2012-04-01T00:00:002012Radiotherapy in the adjuvant management of pancreatic adenocarcinoma: is it helpful?27422109Oncology (Williston Park, N.Y.)ACR Appropriateness Criteria? Borderline and Unresectable Pancreas Cancer. Oncology (Williston Park). 2016 Jul; 30(7):619-24, 627, 632.Oncology (Williston Park)2016-07-01T00:00:002016ACR Appropriateness Criteria? Borderline and Unresectable Pancreas Cancer.Rush University, Rush Medical Collegetrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor